Spur Capital Partners LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Spur Capital Partners LLC
CRD #115959
SEC #801-60804
CIK #0001303109
AUM
Employees 9 (56% Investors, 0% Brokers)
Fees
Minimum
Phone918-331-3800
Address2370 Nowata Place
Bartlesville, OK 74006
Source [IAPD] [EDGAR] [Website] [Twitter] [LinkedIn]
Total AUM ($M)
1300104078052026002002201020182026
Fees and Compensation — Form ADV Part 2A (3/31/2025) [Brochure]
Item 5 – Fees and Compensation

 In exchange for the management and administration of Spur Funds, Spur Capital receives a
 management fee as described in the Limited Partnership Agreement. Annual management fees
 typically range from 0.50% to 0.70% of each investor’s committed capital. The fee is assessed
 and paid quarterly in advance and is non-negotiable and non-refundable. This fee is deducted from
 the Client’s assets on the first day of each quarter.

In addition to management fees, investors bear indirectly the expenses charged to each Spur Capital Fund.
Each Fund will pay, or reimburse Spur Capital, for organizational expenses of the Fund, the General Partner
and affiliated entities; liquidation expenses of the Fund, the General Partner and affiliated entities; the costs
and expenses of the identification, evaluation, negotiation, acquisition, due diligence, restructuring, closing,
holding, monitoring, and disposition of investments for a Fund (whether or not consummated); fees or
government charges which may be assessed against the Fund; commissions or brokerage fees or similar
charges incurred in connection with the purchase or sale of securities (including any merger fees payable to
third parties and whether or not any such purchase or sale is consummated); and fees (if any) and expenses of
members of the Advisory Board (including travel-related costs and expenses).

Additional information regarding fees and expenses is included in the Limited Partnership Agreement of each
Spur Capital Fund.

Spur Capital may, from time to time, organize other investment vehicles that have different investment
objectives and different fee structures.
Account Minimums and Types of Clients — Form ADV Part 2A (3/31/2025) [Brochure]
Item 7 – Types of Clients

 Spur Capital provides portfolio management services to its Clients which are fund-of-funds
 investment vehicles that invest primarily in venture capital partnerships. Investors in the Funds
 include non-US financial institutions, U.S foundations and other institutional or accredited
 investors.
Type Form D Funds Date Sold AUM
VC Spur Ventures LP 2012-03-30 11.6 M
AUM Breakdown Accounts AUM ($M)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 8 879.9
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 8 879.9
By Discretionary
Discretionary 8 879.9
Non-Discretionary 0 0.0
Total 8 879.9
By Non-United States Persons
Non-United States Persons 0.0
United States Persons 879.9
Total 8 879.9
EDGAR Form CIK 2011 - 2026
3 [0001303109]
4 [0001303109]
Firm Profile (Form ADV)
Discretionary AUM$0.3B
ServesInstitutional
Form 3/4/5 Subject 2011 - 2026
Spur Ventures II LP
Constellation Pharmaceuticals Inc
Spur Capital Partners LLC
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Constellation Pharmaceuticals Inc CNST
Common Stock
2018-07-23 Conversion 349,853
Constellation Pharmaceuticals Inc CNST
Series F Preferred Stock · derivative
2018-07-23 Conversion 1,500,000 $0.00
Constellation Pharmaceuticals Inc CNST
Series E Preferred Stock · derivative
2018-07-23 Conversion 888,888 $0.00
Constellation Pharmaceuticals Inc CNST
Series E-1 Preferred Stock · derivative
2018-07-23 Conversion 1,208,678 $0.00
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com